Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005654 | nucleoplasm | 2 | 2 |
GO:0005730 | nucleolus | 5 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043228 | non-membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4QAT1
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_MEL_PAP_1 | 121 | 127 | PF00089 | 0.508 |
CLV_NRD_NRD_1 | 17 | 19 | PF00675 | 0.441 |
CLV_NRD_NRD_1 | 174 | 176 | PF00675 | 0.682 |
CLV_NRD_NRD_1 | 185 | 187 | PF00675 | 0.668 |
CLV_NRD_NRD_1 | 212 | 214 | PF00675 | 0.545 |
CLV_NRD_NRD_1 | 24 | 26 | PF00675 | 0.440 |
CLV_NRD_NRD_1 | 90 | 92 | PF00675 | 0.515 |
CLV_PCSK_FUR_1 | 183 | 187 | PF00082 | 0.581 |
CLV_PCSK_KEX2_1 | 174 | 176 | PF00082 | 0.682 |
CLV_PCSK_KEX2_1 | 180 | 182 | PF00082 | 0.631 |
CLV_PCSK_KEX2_1 | 185 | 187 | PF00082 | 0.473 |
CLV_PCSK_KEX2_1 | 212 | 214 | PF00082 | 0.577 |
CLV_PCSK_KEX2_1 | 222 | 224 | PF00082 | 0.502 |
CLV_PCSK_KEX2_1 | 23 | 25 | PF00082 | 0.445 |
CLV_PCSK_KEX2_1 | 90 | 92 | PF00082 | 0.515 |
CLV_PCSK_PC1ET2_1 | 180 | 182 | PF00082 | 0.531 |
CLV_PCSK_PC1ET2_1 | 222 | 224 | PF00082 | 0.549 |
CLV_PCSK_PC1ET2_1 | 23 | 25 | PF00082 | 0.445 |
CLV_PCSK_PC7_1 | 181 | 187 | PF00082 | 0.532 |
CLV_PCSK_SKI1_1 | 11 | 15 | PF00082 | 0.514 |
CLV_PCSK_SKI1_1 | 25 | 29 | PF00082 | 0.501 |
CLV_PCSK_SKI1_1 | 38 | 42 | PF00082 | 0.556 |
CLV_PCSK_SKI1_1 | 91 | 95 | PF00082 | 0.527 |
CLV_Separin_Metazoa | 8 | 12 | PF03568 | 0.513 |
DEG_APCC_DBOX_1 | 123 | 131 | PF00400 | 0.606 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.467 |
DOC_CYCLIN_RxL_1 | 33 | 45 | PF00134 | 0.557 |
DOC_PP2B_LxvP_1 | 205 | 208 | PF13499 | 0.568 |
DOC_SPAK_OSR1_1 | 198 | 202 | PF12202 | 0.589 |
DOC_USP7_MATH_1 | 120 | 124 | PF00917 | 0.665 |
DOC_USP7_MATH_1 | 133 | 137 | PF00917 | 0.590 |
DOC_USP7_UBL2_3 | 19 | 23 | PF12436 | 0.429 |
LIG_14-3-3_CanoR_1 | 124 | 128 | PF00244 | 0.632 |
LIG_14-3-3_CanoR_1 | 72 | 76 | PF00244 | 0.520 |
LIG_14-3-3_CanoR_1 | 90 | 94 | PF00244 | 0.520 |
LIG_BIR_III_4 | 160 | 164 | PF00653 | 0.562 |
LIG_FHA_1 | 4 | 10 | PF00498 | 0.412 |
LIG_FHA_1 | 92 | 98 | PF00498 | 0.591 |
LIG_FHA_2 | 215 | 221 | PF00498 | 0.427 |
LIG_Integrin_RGD_1 | 186 | 188 | PF01839 | 0.674 |
LIG_SH2_SRC | 77 | 80 | PF00017 | 0.567 |
LIG_SH2_STAP1 | 77 | 81 | PF00017 | 0.563 |
LIG_SH3_2 | 208 | 213 | PF14604 | 0.569 |
LIG_SH3_3 | 205 | 211 | PF00018 | 0.511 |
LIG_SUMO_SIM_anti_2 | 6 | 11 | PF11976 | 0.491 |
LIG_TRAF2_1 | 148 | 151 | PF00917 | 0.606 |
LIG_TRAF2_1 | 226 | 229 | PF00917 | 0.674 |
MOD_CK1_1 | 123 | 129 | PF00069 | 0.604 |
MOD_CK1_1 | 48 | 54 | PF00069 | 0.587 |
MOD_CK1_1 | 80 | 86 | PF00069 | 0.587 |
MOD_CK1_1 | 89 | 95 | PF00069 | 0.591 |
MOD_CK2_1 | 116 | 122 | PF00069 | 0.687 |
MOD_CK2_1 | 145 | 151 | PF00069 | 0.607 |
MOD_CK2_1 | 214 | 220 | PF00069 | 0.572 |
MOD_CK2_1 | 89 | 95 | PF00069 | 0.597 |
MOD_GlcNHglycan | 117 | 121 | PF01048 | 0.562 |
MOD_GlcNHglycan | 135 | 138 | PF01048 | 0.596 |
MOD_GlcNHglycan | 47 | 50 | PF01048 | 0.606 |
MOD_GlcNHglycan | 59 | 62 | PF01048 | 0.637 |
MOD_GSK3_1 | 116 | 123 | PF00069 | 0.724 |
MOD_GSK3_1 | 141 | 148 | PF00069 | 0.768 |
MOD_GSK3_1 | 44 | 51 | PF00069 | 0.567 |
MOD_GSK3_1 | 52 | 59 | PF00069 | 0.558 |
MOD_GSK3_1 | 80 | 87 | PF00069 | 0.604 |
MOD_GSK3_1 | 89 | 96 | PF00069 | 0.560 |
MOD_NEK2_1 | 116 | 121 | PF00069 | 0.515 |
MOD_NEK2_1 | 214 | 219 | PF00069 | 0.451 |
MOD_NEK2_1 | 93 | 98 | PF00069 | 0.595 |
MOD_PKA_2 | 123 | 129 | PF00069 | 0.630 |
MOD_PKA_2 | 71 | 77 | PF00069 | 0.543 |
MOD_PKA_2 | 89 | 95 | PF00069 | 0.643 |
MOD_Plk_1 | 77 | 83 | PF00069 | 0.572 |
MOD_Plk_2-3 | 145 | 151 | PF00069 | 0.601 |
MOD_Plk_4 | 71 | 77 | PF00069 | 0.521 |
TRG_DiLeu_BaEn_4 | 150 | 156 | PF01217 | 0.587 |
TRG_ER_diArg_1 | 211 | 213 | PF00400 | 0.572 |
TRG_NLS_Bipartite_1 | 212 | 226 | PF00514 | 0.566 |
TRG_NLS_MonoExtC_3 | 221 | 227 | PF00514 | 0.545 |
TRG_Pf-PMV_PEXEL_1 | 212 | 216 | PF00026 | 0.564 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HZZ3 | Leptomonas seymouri | 49% | 100% |
A0A3S7WYA2 | Leishmania donovani | 86% | 98% |
A4HDA7 | Leishmania braziliensis | 71% | 99% |
A4I0P0 | Leishmania infantum | 86% | 98% |
E9AWP0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 87% | 98% |
V5C0P2 | Trypanosoma cruzi | 32% | 100% |